A Comprehensive Review of AIM2 in Cancer: Functional Roles, Molecular Pathways, and Clinical Relevance

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Inflammation is a known factor in cancer progression.
• The AIM2 inflammasome regulates key biological processes like cell proliferation and tumorigenesis.
• AIM2 influences tumor progression through mechanisms including negative regulation of STING-dependent type I interferon signaling.

Purpose of the Study:

• To review the diverse roles of the AIM2 inflammasome in different cancer types.
• To discuss the potential clinical applications of AIM2 in cancer therapy.
• To provide evidence supporting AIM2 as a molecular target for cancer immunotherapy.

Main Methods:

• Literature review of studies on AIM2 inflammasome in various cancers.
• Analysis of AIM2's mechanisms of action in tumor progression.
• Exploration of AIM2's interplay with interferon signaling pathways.

Main Results:

• The AIM2 inflammasome plays a significant role in tumor progression across multiple cancers.
• AIM2 negatively regulates STING-dependent type I interferon signaling, impacting anti-tumor immunity.
• Extensive research exists for AIM2 in colorectal cancer, with emerging evidence in other malignancies.

Conclusions:

• AIM2 is a potential molecular target for developing novel cancer immunotherapies.
• Understanding AIM2's diverse functions can lead to improved cancer treatment strategies.
• Further research into AIM2's clinical applications is warranted for advancing cancer therapy.